Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer

Anticancer Research

Volumn 21, Issue 4 B, 2001, Pages 2957-2961

  Su, S S ^a   Che, T C ^a   Ye, R F ^a   She, Y Y ^a   Changla, S P ^a   Kao, A ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

18F fluoro 2 deoxyglucose positron emission tomography; Cervical cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ADULT; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 0035174608     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Estimates of the worldwide frequency of sixteen major cancers in 1980
2. Cancer statistics
3. Radiology in invasive cervical cancer
4. Cervical carcinoma: Role of imaging
5. Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: Potential role in oncologic imaging
6. The role of PET imaging in clinical oncology: A current status report
7. Fluorodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors
8. Revised FIGO staging for gynaecological cancer
9. Technical improvements in fluorine-18-FDG PET imaging of the abdomen and pelvis
10. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic tracer for rapid tumor detection
11. The applications of PET in clinical oncology
12. Positron emission tomography as a diagnostic tool in oncology
13. Malignant cervical lesions
14. The occurrence of metastasis outside the abdomen and retroperitoneal space in invasive carcinoma of the cervix
15. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography